PositiveID (PSID) Achieves Positive Preliminary Results for Glucose-sensing Diabetes Device
PositiveID Corp., a developer of medical technologies for diabetes management, today announced that preliminary results from its biotransport research study with the Diabetes Research Institute (DRI) at the University of Miami demonstrate positive data for the company’s GlucoChip ™. PositiveID's GlucoChip is a glucose-sensing implantable microchip, currently under development with RECEPTORS LLC, for individuals with diabetes. The company reports that preliminary results demonstrate that the membrane materials to be used with GlucoChip allow for successful movement of glucose from body fluids. "These first studies were successfully completed with the demonstration that a glucose tracer readily enters the device from surrounding…